Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $150.00 at Oppenheimer

Addus HomeCare (NASDAQ:ADUS - Get Free Report) had its target price hoisted by Oppenheimer from $145.00 to $150.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Oppenheimer's price target would suggest a potential upside of 14.84% from the company's previous close.

A number of other analysts also recently issued reports on the stock. Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a report on Wednesday, November 6th. KeyCorp began coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective on the stock. Royal Bank of Canada reiterated an "outperform" rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. JMP Securities initiated coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an "outperform" rating and a $150.00 price objective on the stock. Finally, Macquarie restated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average price target of $134.22.

Addus HomeCare Price Performance

ADUS traded up $3.51 during trading on Friday, reaching $130.62. The company had a trading volume of 132,235 shares, compared to its average volume of 103,123. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.72. The business's fifty day moving average price is $126.10 and its 200 day moving average price is $126.96. The company has a market cap of $2.37 billion, a P/E ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. During the same period last year, the company earned $1.03 earnings per share. The firm's revenue was up 7.1% compared to the same quarter last year. As a group, sell-side analysts predict that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares of the company's stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the company's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company's stock, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by insiders.

Institutional Trading of Addus HomeCare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quarry LP acquired a new stake in Addus HomeCare during the 3rd quarter valued at approximately $28,000. Farther Finance Advisors LLC boosted its holdings in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock worth $49,000 after buying an additional 366 shares in the last quarter. KBC Group NV boosted its holdings in shares of Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after buying an additional 268 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Addus HomeCare by 25.7% during the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company's stock worth $124,000 after buying an additional 191 shares in the last quarter. Finally, Assetmark Inc. boosted its holdings in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company's stock worth $156,000 after buying an additional 121 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.